White D, Mongeluzi D, Curry A, Donu D, Cen Y
RSC Adv. 2022; 12(4):2219-2226.
PMID: 35425235
PMC: 8979134.
DOI: 10.1039/d1ra08794k.
Tozaki-Saitoh H, Takeda H, Inoue K
Molecules. 2022; 27(6).
PMID: 35335282
PMC: 8949888.
DOI: 10.3390/molecules27061919.
Warma A, Lussier J, Ndiaye K
Int J Mol Sci. 2021; 22(4).
PMID: 33546420
PMC: 7913596.
DOI: 10.3390/ijms22041533.
Li P, Li X, Deng P, Wang D, Bai X, Li Y
Aging (Albany NY). 2020; 13(1):694-713.
PMID: 33253120
PMC: 7835045.
DOI: 10.18632/aging.202178.
Jacobson K, Moro S, Kim Y, Li A
Drug Dev Res. 2019; 45(3-4):113-124.
PMID: 31808655
PMC: 6893906.
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<113::AID-DDR5>3.0.CO;2-S.
Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.
Abedi H, Aghaei M, Panjehpour M, Hajiahmadi S
Tumour Biol. 2014; 35(11):11027-39.
PMID: 25095978
DOI: 10.1007/s13277-014-2396-9.
Purinoceptors on neuroglia.
Verkhratsky A, Verkhrasky A, Krishtal O, Burnstock G
Mol Neurobiol. 2009; 39(3):190-208.
PMID: 19283516
DOI: 10.1007/s12035-009-8063-2.
G protein-independent neuromodulatory action of adenosine on metabotropic glutamate signalling in mouse cerebellar Purkinje cells.
Tabata T, Kawakami D, Hashimoto K, Kassai H, Yoshida T, Hashimotodani Y
J Physiol. 2007; 581(Pt 2):693-708.
PMID: 17379632
PMC: 2075187.
DOI: 10.1113/jphysiol.2007.129866.
The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.
van Calker D, Biber K
Neurochem Res. 2005; 30(10):1205-17.
PMID: 16341582
DOI: 10.1007/s11064-005-8792-1.
Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Hashemi M, Karami-Tehrani F, Ghavami S, Maddika S, Los M
Cell Prolif. 2005; 38(5):269-85.
PMID: 16202036
PMC: 6495740.
DOI: 10.1111/j.1365-2184.2005.00349.x.
Adenosine receptor signaling in the brain immune system.
Hasko G, Pacher P, Vizi E, Illes P
Trends Pharmacol Sci. 2005; 26(10):511-6.
PMID: 16125796
PMC: 2228262.
DOI: 10.1016/j.tips.2005.08.004.
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
Fredholm B, IJzerman A, Jacobson K, Klotz K, Linden J
Pharmacol Rev. 2001; 53(4):527-52.
PMID: 11734617
PMC: 9389454.
Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity.
Shneyvays V, Mamedova L, Zinman T, Jacobson K, Shainberg A
J Mol Cell Cardiol. 2001; 33(6):1249-61.
PMID: 11444927
PMC: 10792614.
DOI: 10.1006/jmcc.2001.1387.
Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.
Shneyvays V, Jacobson K, Li A, Nawrath H, Zinman T, Isaac A
Exp Cell Res. 2000; 257(1):111-26.
PMID: 10854059
PMC: 10792615.
DOI: 10.1006/excr.2000.4882.
Apoptosis by 2-chloro-2'-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells.
Barbieri D, Abbracchio M, Salvioli S, Monti D, Cossarizza A, Ceruti S
Neurochem Int. 1998; 32(5-6):493-504.
PMID: 9676749
PMC: 6906928.
DOI: 10.1016/s0197-0186(97)00129-0.
Adenosine A3 receptors: novel ligands and paradoxical effects.
Jacobson K
Trends Pharmacol Sci. 1998; 19(5):184-91.
PMID: 9652191
PMC: 3158240.
DOI: 10.1016/s0165-6147(98)01203-6.
Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells.
Brodie C, Blumberg P, Jacobson K
FEBS Lett. 1998; 429(2):139-42.
PMID: 9650577
PMC: 5454773.
DOI: 10.1016/s0014-5793(98)00556-0.